HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The impact of comprehensive stroke care capacity on the hospital volume of stroke interventions: a nationwide study in Japan: J-ASPECT study.

AbstractBACKGROUND:
The association between comprehensive stroke care capacity and hospital volume of stroke interventions remains uncertain. We performed a nationwide survey in Japan to examine the impact of comprehensive stroke care capacity on the hospital volume of stroke interventions.
METHODS:
A questionnaire on hospital characteristics, having tissue plasminogen activator (t-PA) protocols, and 25 items regarding personnel, diagnostic, specific expertise, infrastructure, and educational components recommended for comprehensive stroke centers (CSCs) was sent to 1369 professional training institutions. We examined the effect of hospital characteristics, having a t-PA protocol, and the number of fulfilled CSC items (total CSC score) on the hospital volume of t-PA infusion, removal of intracerebral hemorrhage, and coiling and clipping of intracranial aneurysms performed in 2009.
RESULTS:
Approximately 55% of hospitals responded to the survey. Facilities with t-PA protocols (85%) had a significantly higher likelihood of having 23 CSC items, for example, personnel (eg, neurosurgeons: 97.3% versus 66.1% and neurologists: 51.3% versus 27.7%), diagnostic (eg, digital cerebral angiography: 87.4% versus 43.2%), specific expertise (eg, clipping and coiling: 97.2% and 54% versus 58.9% and 14.3%, respectively), infrastructure (eg, intensive care unit: 63.9% versus 33.9%), and education (eg, professional education: 65.2% versus 20.7%). On multivariate analysis adjusted for hospital characteristics, total CSC score, but not having a t-PA protocol, was associated with the volume of all types of interventions with a clear increasing trend (P for trend < .001).
CONCLUSION:
We demonstrated a significant association between comprehensive stroke care capacity and the hospital volume of stroke interventions in Japan.
AuthorsKoji Iihara, Kunihiro Nishimura, Akiko Kada, Jyoji Nakagawara, Kazunori Toyoda, Kuniaki Ogasawara, Junichi Ono, Yoshiaki Shiokawa, Toru Aruga, Shigeru Miyachi, Izumi Nagata, Shinya Matsuda, Koichi B Ishikawa, Akifumi Suzuki, Hisae Mori, Fumiaki Nakamura, J-ASPECT Study Collaborators
JournalJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association (J Stroke Cerebrovasc Dis) 2014 May-Jun Vol. 23 Issue 5 Pg. 1001-18 ISSN: 1532-8511 [Electronic] United States
PMID24103675 (Publication Type: Journal Article, Multicenter Study)
CopyrightCopyright © 2014 National Stroke Association. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Fibrinolytic Agents
  • Tissue Plasminogen Activator
Topics
  • Comprehensive Health Care (trends)
  • Delivery of Health Care, Integrated (trends)
  • Embolization, Therapeutic (trends)
  • Fibrinolytic Agents (administration & dosage)
  • Health Care Surveys
  • Health Services Accessibility (trends)
  • Healthcare Disparities (trends)
  • Hospitals, High-Volume (trends)
  • Hospitals, Low-Volume (trends)
  • Humans
  • Japan
  • Linear Models
  • Multivariate Analysis
  • Neurosurgical Procedures (trends)
  • Outcome and Process Assessment, Health Care (trends)
  • Patient Care Team (trends)
  • Stroke (diagnosis, therapy)
  • Surveys and Questionnaires
  • Thrombolytic Therapy (trends)
  • Tissue Plasminogen Activator (administration & dosage)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: